Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116504274 | 11650427 | 4 | F | 20160809 | 20151021 | 20160822 | EXP | US-BAYER-2015-444034 | BAYER | 23.00 | YR | A | F | Y | 0.00000 | 20160822 | CN | GB | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116504274 | 11650427 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 500 MG, BID | N | 21473 | 500 | MG | MODIFIED-RELEASE FILM-COATED TABLET | BID | ||||||
| 116504274 | 11650427 | 2 | SS | MOXIFLOXACIN ORAL | MOXIFLOXACIN | 1 | 400 MG, QD | 0 | 400 | MG | FILM-COATED TABLET | QD | |||||||
| 116504274 | 11650427 | 3 | SS | MOXIFLOXACIN ORAL | MOXIFLOXACIN | 1 | 0 | FILM-COATED TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116504274 | 11650427 | 1 | Diarrhoea infectious |
| 116504274 | 11650427 | 2 | Oropharyngeal pain |
| 116504274 | 11650427 | 3 | Pyrexia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116504274 | 11650427 | DS |
| 116504274 | 11650427 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116504274 | 11650427 | Alopecia | |
| 116504274 | 11650427 | Amnesia | |
| 116504274 | 11650427 | Arthralgia | |
| 116504274 | 11650427 | Cognitive disorder | |
| 116504274 | 11650427 | Decreased appetite | |
| 116504274 | 11650427 | Disturbance in attention | |
| 116504274 | 11650427 | Dizziness | |
| 116504274 | 11650427 | Dry eye | |
| 116504274 | 11650427 | Dry mouth | |
| 116504274 | 11650427 | Dyspnoea | |
| 116504274 | 11650427 | Fatigue | |
| 116504274 | 11650427 | Food intolerance | |
| 116504274 | 11650427 | Gastrointestinal pain | |
| 116504274 | 11650427 | Gastrooesophageal reflux disease | |
| 116504274 | 11650427 | Hypotension | |
| 116504274 | 11650427 | Impaired gastric emptying | |
| 116504274 | 11650427 | Insomnia | |
| 116504274 | 11650427 | Irritable bowel syndrome | |
| 116504274 | 11650427 | Micturition urgency | |
| 116504274 | 11650427 | Migraine | |
| 116504274 | 11650427 | Mood swings | |
| 116504274 | 11650427 | Multiple chemical sensitivity | |
| 116504274 | 11650427 | Muscle contractions involuntary | |
| 116504274 | 11650427 | Muscular weakness | |
| 116504274 | 11650427 | Myalgia | |
| 116504274 | 11650427 | Mydriasis | |
| 116504274 | 11650427 | Nausea | |
| 116504274 | 11650427 | Orthostatic intolerance | |
| 116504274 | 11650427 | Seizure | |
| 116504274 | 11650427 | Sensory disturbance | |
| 116504274 | 11650427 | Sinus disorder | |
| 116504274 | 11650427 | Sinusitis | |
| 116504274 | 11650427 | Tachycardia | |
| 116504274 | 11650427 | Tendonitis | |
| 116504274 | 11650427 | Toxicity to various agents | |
| 116504274 | 11650427 | Ulcerative keratitis | |
| 116504274 | 11650427 | Upper respiratory tract infection | |
| 116504274 | 11650427 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |